Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Chemotherapy-induced Thrombocytopenia × hetrombopag × Classical hematology × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Thrombocytopenia 2 Chemotherapy-Induced Thrombocytopenia 2 Digestive System Diseases 1 Chemotherapy-induced Thrombocytopenia 1 Chemotherapy Induced Thrombocytopenia 1 Cancer Therapy-induced Thrombocytopenia (CTIT) 1

Interventions

oprelvekin 1 hetrombopag 1 eltrombopag 1 avatrombopag 1 Interleukin-11 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06099925 2023-10-25

The Efficacy and Safety of Hetrombopag as Secondary Prevention to Chemotherapy-induced Thrombocytopenia in Patients With Gynecologic Malignancies

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Unknown

Classical hematology

Chemotherapy-induced Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡